"The CRO they are initiating probably is a lab just to make specialty organic molecule/conjugates for immunization programs and has probably grown out of DiaSource Vit D expertise."
I wondered about this and given the latest ADO 4C commentary showed no nett gain to the staffing numbers. CROs can be resource intensive - so maybe they have opened a JV/subcontract with an estsblished CRO - if so its not improbable that it is Aepodia. Just a hunch as, neither acknowledge the other via websites, but they are BIOWIN fellows and within the same precinct.
Vit D focused CROs, such as Rho Federal Systems & Alliance Pharma, are few & far between. With increasing numbers of Vit D test providers, avoiding conflict of interest by CROs would be difficult.
- Forums
- ASX - By Stock
- Complex Organic Molecules
"The CRO they are initiating probably is a lab just to make...
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $59.24M |
Open | High | Low | Value | Volume |
2.2¢ | 2.4¢ | 2.2¢ | $54.26K | 2.389M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 197573 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 124808 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 197573 | 0.023 |
3 | 340301 | 0.022 |
8 | 1458170 | 0.021 |
12 | 1946809 | 0.020 |
8 | 1129867 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 124808 | 2 |
0.025 | 240865 | 5 |
0.028 | 190000 | 1 |
0.029 | 34000 | 3 |
0.030 | 350000 | 1 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |